TLR3 and pancreatic adenocarcinoma: Overexpression of TLR3 was associated with prolonged PFI, DFS, OS and DSS in patients with KIRC, while suppressed expression of TLR3 was associated with prolonged PFI, DFS, OS and DSS in patients with LGG, and suppressed expression of TLR3 was associated with prolonged DFI and OS in patients with PAAD.